8-K/AMaterial Agreements

Elevance Health, Inc. 8-K/A Report, Material Agreement (Mar 29, 2006)

Filed March 29, 2006For Securities:ELV

Summary

This filing is an amendment (8-K/A) to a previously filed Form 8-K by WellPoint, Inc. (now Elevance Health, Inc.) on March 3, 2006. The primary purpose of this amendment is to correct the number of 2006 Restricted Stock Awards granted to the named executive officers. The original filing incorrectly stated the award numbers. This revised filing clarifies the precise number of restricted stock units awarded to key executives, including Larry C. Glasscock, David C. Colby, Keith R. Faller, Joan E. Herman, and John S. Watts, Jr., as of March 1, 2006. The awards were granted at the fair market value of $76.59 per share and are set to vest over three years, commencing March 1, 2007. Investors should note that this amendment does not alter any other aspects of the original 8-K filing.

Key Highlights

  • 1Amendment to a previous Form 8-K filing from March 3, 2006.
  • 2Correction pertains specifically to the number of 2006 Restricted Stock Awards granted to executive officers.
  • 3Awards were granted on March 1, 2006.
  • 4The fair market value at the time of the award was $76.59 per share.
  • 5Restricted stock awards will vest in three equal annual installments over three years.
  • 6Vesting begins on March 1, 2007.
  • 7No other portions of the original Form 8-K are being amended.

Frequently Asked Questions

This filing is an amendment to a prior Form 8-K to correct an error in the originally reported number of 2006 Restricted Stock Awards granted to WellPoint's named executive officers.

The corrected 2006 Restricted Stock Awards were granted on March 1, 2006.

The restricted stock awards will vest in three equal annual installments, with the vesting period beginning on March 1, 2007.

The awards were made at the fair market value, which was the closing market value of WellPoint's Common Stock on March 1, 2006, amounting to $76.59 per share.